ResMed reported $3.51B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Ansell USD 1.11B 5.2M Dec/2025
Artivion USD 338.81M 32.57M Sep/2026
AtriCure USD 363.39M 17.86M Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Cochlear AUD 1.37B 43.9M Dec/2025
Cooper Companies USD 2.28B 18.3M Jun/2026
CSL USD 11.85B 1000K Dec/2025
Dexcom USD 3.92B 170.6M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Fisher Paykel Healthcare NZD 1.15B 168.5M Jun/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Haemonetics USD 855.53M 44.7M Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Philips EUR 10.51B 1.18B Sep/2026
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 3.51B 815.82M Sep/2026
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Steris USD 2.48B 33.4M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026